You are here

  • Home
  • Archive
  • Volume 4, Issue 12
  • Discontinuation of infliximab therapy in patients with Crohn's disease in sustained complete remission (the STOP IT study): protocol for a double-blind, randomised, placebo-controlled, multicentre trial

Citation Tools

Article menu

Download PDFPDF

XML
Gastroenterology and hepatology
Protocol
Discontinuation of infliximab therapy in patients with Crohn's disease in sustained complete remission (the STOP IT study): protocol for a double-blind, randomised, placebo-controlled, multicentre trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Buhl SS, Steenholdt C, Brynskov J, et al
Discontinuation of infliximab therapy in patients with Crohn's disease in sustained complete remission (the STOP IT study): protocol for a double-blind, randomised, placebo-controlled, multicentre trial
BMJ Open 2014;4:e005887. doi: 10.1136/bmjopen-2014-005887